BindingDB logo
myBDB logout

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
10560740 23 The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives.EBI SmithKline Beecham Pharmaceuticals
15055990 37 Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.EBI Wyeth Research
14521407 87 Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.EBI GlaxoSmithKline Research and Development
12067545 22 Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: potency and plasma stability.EBI GlaxoSmithKline Research and Development
11754575 51 Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality.EBI GlaxoSmithKline Research and Development
10091700 36 Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism.EBI SmithKline Beecham Pharmaceuticals
9934494 20 Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease.EBI SmithKline Beecham Pharmaceuticals
9871780 85 Inhibition of human cytomegalovirus protease N(o) with monocyclic beta-lactams.EBI Boehringer Ingelheim (Canada) Ltd
9871686 23 Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease.EBI Glaxo Wellcome Research and Development
24977643 9 Broad-spectrum allosteric inhibition of herpesvirus proteases.BDB University of California at San Francisco